Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis. [PDF]
BACKGROUND: Treatment with glucocorticoids is associated with bone loss starting soon after therapy is initiated and an increased risk of fracture. METHODS: We performed a randomized, double-placebo, double-blind clinical trial of 18 months' duration ...
Buskens, E.; id_orcid +19 more
core +12 more sources
Quantification of Alfacalcidol Tablets Dissolution Content by Chemical Derivatization and LC-MS
Application of liquid chromatography-mass spectrometry (LC-MS) in analyzing the content of alfacalcidol tablets dissolution faces big challenges due to the low amount of alfacalcidol in each tablet and the low ionization efficacy of the compound with ...
Yang Liu +5 more
doaj +2 more sources
Alfacalcidol is an active synthetic preparation of vitamin D, characterized by high bioavailability and broad pharmacological properties. The article substantiates the possibility of widespread use of alfacalcidol in children and adolescents with ...
V. V. Smirnov, S. A. Miroshnichenko
doaj +1 more source
Pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized controlled trial [PDF]
Osama Sawalmeh,1 Shaheed Moala,1 Zakaria Hamdan,2 Huda Masri,3 Khubaib Ayoub,4 Emad Khazneh,2 Mujahed Shraim5 1Medicine Department, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine; 2Nephrology Department ...
Sawalmeh O +6 more
doaj +3 more sources
Effects of the inclusion of alfacalcidol in complex rehabilitation programs for patients with age-related facial ptosis [PDF]
Introduction. The sufficiency of vitamin D is important for slowing down the aging of the skin, maintaining its hydration, elasticity and the ability to regenerate. Biologically active forms of vitamin D (including alfacalcidol) promote the activation of
O. A. Gromova +3 more
doaj +2 more sources
Jun Iwamoto,1 Yoshihiro Sato,2 Mitsuyoshi Uzawa,3 Hideo Matsumoto11Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, 2Department of Neurology, Mitate Hospital, Fukuoka, 3Department of Orthopaedic Surgery, Keiyu ...
Iwamoto J, Sato Y, Uzawa M, Matsumoto H
doaj +1 more source
Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol [PDF]
Background Secondary hyperparathyroidism is a common feature in patients with chronic kidney disease. Its serious clinical consequences include renal osteodystrophy, calcific uremic arteriolopathy, and vascular calcifications that increase morbidity and ...
Brandi Lisbet +2 more
doaj +3 more sources
ObjectivesTo investigate the growth velocity-improving effects of vitamin D replacement therapy in pediatric patients diagnosed with vitamin D deficiency and insufficiency.Study designA retrospective cohort study was conducted in 34 pediatric patients ...
Satoshi Miyagaki +6 more
doaj +2 more sources
Symptomatic Ferric Carboxymaltose-Induced Hypophosphataemia: A Case Series of 11 Patients. [PDF]
eJHaem, Volume 7, Issue 4, August 2026.
Weerheim M +6 more
europepmc +2 more sources
Effect of canagliflozin combined with alfacalcidol in the treatment of elderly type 2 diabetes mellitus with osteoporosis [PDF]
Objective To investigate the clinical efficacy of canagliflozin combined with alfacalcidol in the treatment of elderly patients with type 2 diabetes mellitus(T2DM)and osteoporosis. Methods A randomized controlled trial design was adopted.
HUANG Yi*,JIANGXiong,PENG Jun,GUI Xiao,LIU Shuang,LI Peng,LI Yanling,JIANG Meiling
doaj +2 more sources

